119-hr1143

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1143 Introduced in House

    (IH) ]

<DOC>

119th CONGRESS
 1st Session
 H. R. 1143

 To amend title XVIII of the Social Security Act to expand coverage of 
 the in-home administration of intravenous immune globulin under the 
 Medicare program.

_______________________________________________________________________

 IN THE HOUSE OF REPRESENTATIVES

 February 7, 2025

 Mr. Smith of Nebraska (for himself and Mr. Garamendi) introduced the 
 following bill; which was referred to the Committee on Energy and 
 Commerce, and in addition to the Committee on Ways and Means, for a 
 period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
 committee concerned

_______________________________________________________________________

 A BILL

 To amend title XVIII of the Social Security Act to expand coverage of 
 the in-home administration of intravenous immune globulin under the 
 Medicare program.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

 This Act may be cited as the ``Medicare IVIG Access Enhancement Act 
of 2025''.

SEC. 2. EXPANDING COVERAGE OF THE IN-HOME ADMINISTRATION OF INTRAVENOUS 
 IMMUNE GLOBULIN UNDER THE MEDICARE PROGRAM.

    (a) In General.--

Section 1861 of the Social Security Act (42 U.S.C. 
1395x) is amended--

    (1) in subsection

    (s)

    (2)
        (Z) , by inserting ``(and, beginning 
 January 1, 2027, for the treatment of chronic inflammatory 
 demyelinating polyneuropathy and multifocal motor neuropathy)'' 
 after ``primary immune deficiency diseases''; and

    (2) in subsection

    (zz) , by inserting ``(or, beginning 
 January 1, 2027, with diagnosed chronic inflammatory 
 demyelinating polyneuropathy and multifocal motor neuropathy)'' 
 after ``primary immune deficiency disease''.

    (b) Authority for Variance in Payments.--

Section 1842

    (o)

    (8) of the 
Social Security Act (42 U.S.C. 1395u

    (o)

    (8) ) is amended by inserting 
``and may vary depending on whether such administration is related to 
treatment of a primary immune deficiency disease or the treatment of 
chronic inflammatory demyelinating polyneuropathy or multifocal motor 
neuropathy (as determined appropriate by the Secretary through notice 
and comment rulemaking)'' after ``of 2012''.
 <all>